CRDL – cardiol therapeutics inc. - class a common shares (US:NASDAQ)
Stock Stats
News
Cardiol Therapeutics CEO: Phase III MAVERIC Nears Full Enrollment as CardiolRx Shows Myocarditis Promise [Yahoo! Finance]
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart [Yahoo! Finance]
Cardiol Therapeutics (CRDL) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $8.00 price target on the stock.
Cardiol Therapeutics (CRDL) was upgraded by Wall Street Zen from "sel
Cardiol Therapeutics Touts Phase III MAVERIC Timeline for CardiolRx at TD Cowen Healthcare Conference [Yahoo! Finance]
Form 6-K Cardiol Therapeutics For: Apr 14
Form 6-K Cardiol Therapeutics For: Apr 10
Form 6-K Cardiol Therapeutics For: Apr 01
Form 40-F Cardiol Therapeutics For: Dec 31
Form 6-K Cardiol Therapeutics For: Feb 25
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.